1. Home
  2. RVSB vs HURA Comparison

RVSB vs HURA Comparison

Compare RVSB & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

N/A

Current Price

$6.11

Market Cap

120.5M

Sector

Finance

ML Signal

N/A

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

N/A

Current Price

$1.63

Market Cap

123.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RVSB
HURA
Founded
1923
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
120.5M
123.0M
IPO Year
1997
2010

Fundamental Metrics

Financial Performance
Metric
RVSB
HURA
Price
$6.11
$1.63
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $8.04
AVG Volume (30 Days)
68.8K
★ 392.5K
Earning Date
10-27-2026
11-17-2026
Dividend Yield
★ 1.31%
N/A
EPS Growth
N/A
★ 47.93
EPS
★ 0.08
N/A
Revenue
N/A
N/A
Revenue This Year
$42.74
N/A
Revenue Next Year
$5.53
N/A
P/E Ratio
$76.63
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.88
$0.41
52 Week High
$6.22
$3.43

Technical Indicators

Market Signals
Indicator
RVSB
HURA
Relative Strength Index (RSI) 63.19 38.17
Support Level $5.23 $1.27
Resistance Level $6.22 $2.22
Average True Range (ATR) 0.11 0.19
MACD -0.01 -0.04
Stochastic Oscillator 70.97 8.96

Price Performance

Historical Comparison
RVSB
HURA

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is the bank holding company. The Company's operations are managed along two operating segments, consisting of banking operations performed by the Bank and trust and investment services performed by the Trust Company. The Bank is engaged mainly in the business of attracting deposits from the general public and using such funds, together with other borrowings, to make various commercial business, commercial real estate, land, multi-family real estate, real estate construction and consumer loans. Additionally, the Trust Company offers trust and investment. Its operations into two operating segments, consisting of banking operations and trust and investment services, these operating segments are aggregated into a single reportable operating segment.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Share on Social Networks: